Human papillomavirus awareness and prevention practices among patients with Mayer-Rokitansky-Küster-Hauser syndrome after neovagina reconstruction: a cross-sectional study.
4 affiliations
- 1National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- 2State Key Laboratory for Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Beijing, 100005, China.
- 3National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. [email protected].
- 4State Key Laboratory for Complex Severe and Rare Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Beijing, 100005, China. [email protected].
Abstract
Background
Patients with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) who undergo neovagina reconstruction remain at risk of Human papillomavirus infection (HPV), yet evidence regarding their awareness of HPV-related health risks and engagement in preventive behaviours is limited. This study aimed to assess HPV-related awareness, preventive practices and behavioural factors among Chinese patients with MRKH syndrome after neovagina reconstruction, and to describe HPV screening and vaccination uptake in this population.Methods
A cross-sectional questionnaire-based study was conducted at a tertiary referral hospital in Beijing, China. A total of 157 patients with MRKH syndrome who had undergone neovagina reconstruction completed validated questionnaires assessing HPV awareness, preventive practices and behavioural factors. In addition, outpatient clinical records of 1,756 patients with MRKH syndrome attending specialist care between 2012 and 2024 were retrospectively reviewed to obtain information on HPV testing and ThinPrep cytologic test (TCT) results where available. Descriptive statistical analyses were performed to summarise awareness levels, behavioural characteristics and preventive practice uptake.Results
Most participants demonstrated relatively high awareness of HPV-related health risks: 82.8% recognised their susceptibility to HPV infection and 75.8% expressed support for HPV vaccination. However, preventive practices remained limited. Only 11.5% of participants reported having undergone HPV screening, and 18.5% had received HPV vaccination, indicating a substantial gap between awareness and preventive action. Engagement with routine gynaecological follow-up was generally low. Among those who underwent HPV testing, HPV positivity was detected in a small proportion of patients, with observed rates ranging from 7.4% to 11.1%.Conclusions
Despite relatively high awareness of HPV and its prevention, Chinese patients with MRKH syndrome after neovagina reconstruction showed markedly low uptake of HPV vaccination and limited engagement with HPV testing. These findings highlight an unmet need for accessible HPV vaccination, neovaginal HPV risk education, and tailored sexual health education for this rare and underserved population. Further research is warranted to identify barriers to preventive care and to develop effective interventions to improve HPV prevention practices among women with MRKH syndrome.
Related
- Knowledge, attitudes, and prevention practices regarding human papillomavirus among health and social science female students in Northwest Ethiopia: A comparative cross-sectional study
- Cross-sectional dataset on human papillomavirus (HPV) awareness, vaccination status, and health information sources among adults in five states of Nigeria
- Human papillomavirus (HPV) and HPV vaccine awareness in Indigenous communities in Northwest Territories, Canada
- Healthcare professionals' communication practices and preparedness in organised human papillomavirus-based cervical Cancer screening: A cross-sectional study in Central Portugal.
- Effectiveness of a school-based health education programme in improving myopia awareness, knowledge, attitudes and preventive practices: a pre-post intervention study in Cape Coast, Ghana
BibTeX
@article{zhai2026human,
title = {{Human papillomavirus awareness and prevention practices among patients with Mayer-Rokitansky-Küster-Hauser syndrome after neovagina reconstruction: a cross-sectional study.}},
author = {Yi Zhai and Jia Kang and Lan Zhu and Na Chen},
journal = {BMC women's health},
year = {2026},
month = jul,
doi = {10.1186/s12905-026-04704-8},
url = {https://europepmc.org/article/MED/42902339},
note = {CC BY},
}
RIS
TY - JOUR
TI - Human papillomavirus awareness and prevention practices among patients with Mayer-Rokitansky-Küster-Hauser syndrome after neovagina reconstruction: a cross-sectional study.
AU - Yi Zhai
AU - Jia Kang
AU - Lan Zhu
AU - Na Chen
PY - 2026
DA - 2026/07/01
JO - BMC women's health
DO - 10.1186/s12905-026-04704-8
UR - https://europepmc.org/article/MED/42902339
AB - Background Patients with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) who undergo neovagina reconstruction remain at risk of Human papillomavirus infection (HPV), yet evidence regarding their awareness of HPV-related health risks and engagement in preventive behaviours is limited. This study aimed to assess HPV-related awareness, preventive practices and behavioural factors among Chinese patients with MRKH syndrome after neovagina reconstruction, and to describe HPV screening and vaccination uptake in this population.Methods A cross-sectional questionnaire-based study was conducted at a tertiary referral hospital in Beijing, China. A total of 157 patients with MRKH syndrome who had undergone neovagina reconstruction completed validated questionnaires assessing HPV awareness, preventive practices and behavioural factors. In addition, outpatient clinical records of 1,756 patients with MRKH syndrome attending specialist care between 2012 and 2024 were retrospectively reviewed to obtain information on HPV testing and ThinPrep cytologic test (TCT) results where available. Descriptive statistical analyses were performed to summarise awareness levels, behavioural characteristics and preventive practice uptake.Results Most participants demonstrated relatively high awareness of HPV-related health risks: 82.8% recognised their susceptibility to HPV infection and 75.8% expressed support for HPV vaccination. However, preventive practices remained limited. Only 11.5% of participants reported having undergone HPV screening, and 18.5% had received HPV vaccination, indicating a substantial gap between awareness and preventive action. Engagement with routine gynaecological follow-up was generally low. Among those who underwent HPV testing, HPV positivity was detected in a small proportion of patients, with observed rates ranging from 7.4% to 11.1%.Conclusions Despite relatively high awareness of HPV and its prevention, Chinese patients with MRKH syndrome after neovagina reconstruction showed markedly low uptake of HPV vaccination and limited engagement with HPV testing. These findings highlight an unmet need for accessible HPV vaccination, neovaginal HPV risk education, and tailored sexual health education for this rare and underserved population. Further research is warranted to identify barriers to preventive care and to develop effective interventions to improve HPV prevention practices among women with MRKH syndrome.
SN - 1472-6874
ER -